Common aspirin may block dangerous esophagus condition
NCT ID NCT02521285
Summary
This study is testing whether a daily aspirin pill can help prevent Barrett's esophagus from returning after it has been successfully treated with a procedure called radiofrequency ablation. It involves 21 people who have had their Barrett's esophagus cleared. Participants are randomly assigned to take either aspirin or a placebo (sugar pill) daily for one year, and researchers measure specific markers in tissue samples to see if aspirin makes a difference.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BARRETT ESOPHAGUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
Houston, Texas, 77030, United States
-
Kansas City Veterans Affairs Medical Center
Kansas City, Missouri, 64128, United States
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
-
Northwestern University
Chicago, Illinois, 60611, United States
-
Saint Michael's Hospital
Toronto, Ontario, M5B 1W8, Canada
-
UCHealth University of Colorado Hospital
Aurora, Colorado, 80045, United States
-
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, 90095, United States
-
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, 27599, United States
-
University of Pennsylvania/Abramson Cancer Center
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.